Drug Shortage Report for NIFEDIPINE
Report ID | 198729 |
Drug Identification Number | 00725110 |
Brand name | NIFEDIPINE |
Common or Proper name | Nifedipine |
Company Name | AA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | NIFEDIPINE |
Strength(s) | 5MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 BTL |
ATC code | C08CA |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF. |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-07-28 |
Actual start date | |
Estimated end date | 2023-08-07 |
Actual end date | 2023-07-27 |
Shortage status | Avoided shortage |
Updated date | 2023-08-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2023-08-03 | French | Compare |
v6 | 2023-08-03 | English | Compare |
v5 | 2023-07-31 | French | Compare |
v4 | 2023-07-31 | English | Compare |
v3 | 2023-07-29 | English | Compare |
v2 | 2023-07-14 | French | Compare |
v1 | 2023-07-14 | English | Compare |
Showing 1 to 7 of 7